Crossover Study to Evaluate the Pharmacokinetics of Ezogabine/Retigabine in Taiwanese Subjects
Clinical trial NCT01462669 · COMPLETED
Trial details
- NCT number
- NCT01462669
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-04-10
- Primary completion
- 2012-06-27
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.